Oertel, Wolfgang H. http://orcid.org/0000-0001-6469-6340
Hallström, Yngve
Saletu-Zyhlarz, Gerda M.
Hopp, Michael
Bosse, Björn
Trenkwalder, Claudia
Högl, B.
Röper, C.
Saletu-Zyhlarz, G.
Behrens, S.
Beneš, H.
Bergtholdt, B.
Bitter, R.
Bodenschatz, R.
Böhringer, J.
Boldt, H.-J.
Braune, S.
Donat, P.
Fietze, I.
Franz, P.
Geisler, P.
Gertz, H.-J.
Gestewitz, B.
Haan, J.
Happe, S.
Henin, H.
Hornyak, M.
Hufnagel, A.
Kallmann, B.-A.
Karlbauer, G.
Kassubek, J.
Klein, M.
Koppai-Reiner, J.
Lang, M.
Leibinger, R.
Lüer, W.
Lünser, W.
Mahler, A.
Mattern, W.
Mayer, G.
Molt, W.
Oertel, W.
Peglau, I.
Peltz, J.
Rüttgers, E.
Sallach, K.
Schöll, I.
Schulze, A.
Schumann, V.
Siefjediers, V.
Siever, A.
Sigel, K.-O.
Simonow, A.
Sixel-Döring, F.
Sloksnat, R.
Sommer, H.
Springub, J.
Spieker, T.
Steinwachs, K.-C.
Stiasny-Kolster, K.
Stierstorfer, A.
Storch, A.
Tinschert, K.
Trenkwalder, C.
Veit, B.
Warmuth, R.
Young, P.
Zuchner, D.
García-Borreguero, D.
Iranzo de Riquer, A.
Martinez Rodriguez, J. E.
Puertas, F. J.
Romero Santo-Tomás, O.
Grote, L.
Hallström, Y.
Markström, A.
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension
https://doi.org/10.1007/s40263-016-0372-1
Documents that mention this clinical trial
Funding for this research was provided by:
Mundipharma Research GmbH Co. KG
Article History
First Online: 11 July 2016
Compliance with Ethical Standards
:
: Study protocol and amendments were approved by the national and local ethics committees of the participating study sites, and all participating patients gave written informed consent at enrolment.
: The study was funded by Mundipharma Research GmbH & Co. KG, Limburg, Germany. Writing and editorial support and all publication fees associated with this manuscript were funded by Mundipharma Research GmbH & Co. KG, and included formatting of the manuscript to meet journal guidelines, creation of tables and figures, and the integration of authors’ comments into the manuscript, provided by Elke Grosselindemann and Birgit Brett (Brett Medical Writing Australia/Germany).
: The following authors have received compensation for serving as consultants, speakers, or members of an advisory board: W. Oertel (Abbvie, Adamas, Boehringer Ingelheim, Desitin, Lundbeck, Mundipharma, TEVA, UCB, Zambon); Y. Hallström (Boehringer Ingelheim, Mundipharma, UCB); G. Saletu-Zyhlarz (Servier Austria, Angelini Pharma Austria); C. Trenkwalder (Boehringer Ingelheim; Britannia, Desitin, Abbvie, Mundipharma, Novartis, TEVA, UCB, Vifor). M. Hopp and B. Bosse are employees of Mundipharma.